NO20021686D0 - Methods for Preparation of Target Molecules in a Transgenic Animal and Purification of the Target Molecule - Google Patents

Methods for Preparation of Target Molecules in a Transgenic Animal and Purification of the Target Molecule

Info

Publication number
NO20021686D0
NO20021686D0 NO20021686A NO20021686A NO20021686D0 NO 20021686 D0 NO20021686 D0 NO 20021686D0 NO 20021686 A NO20021686 A NO 20021686A NO 20021686 A NO20021686 A NO 20021686A NO 20021686 D0 NO20021686 D0 NO 20021686D0
Authority
NO
Norway
Prior art keywords
methods
purification
target molecules
target
preparation
Prior art date
Application number
NO20021686A
Other languages
Norwegian (no)
Other versions
NO20021686L (en
Inventor
Harry M Meade
Scott P Fulton
Yann Echelard
Original Assignee
Genzyme Transgenics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Transgenics Corp filed Critical Genzyme Transgenics Corp
Publication of NO20021686D0 publication Critical patent/NO20021686D0/en
Publication of NO20021686L publication Critical patent/NO20021686L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides systems and methods for the production and purification of target molecules present in biological systems. The systems and methods according to the invention utilize transgenic expression of multivalent binding polypeptides, as affinity media, to purify such target molecules. The transgenic multivalent binding polypeptides bind both the target molecules, e.g., a bindable epitope of a target molecule, and a matrix.
NO20021686A 1999-10-14 2002-04-10 Methods for Preparation of Target Molecules in a Transgenic Animal and Purification of the Target Molecule NO20021686L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15974899P 1999-10-14 1999-10-14
US20466200P 2000-05-17 2000-05-17
PCT/US2000/028589 WO2001026455A1 (en) 1999-10-14 2000-10-16 Methods of producing a target molecule in a transgenic animal and purification of the target molecule

Publications (2)

Publication Number Publication Date
NO20021686D0 true NO20021686D0 (en) 2002-04-10
NO20021686L NO20021686L (en) 2002-06-12

Family

ID=26856252

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021686A NO20021686L (en) 1999-10-14 2002-04-10 Methods for Preparation of Target Molecules in a Transgenic Animal and Purification of the Target Molecule

Country Status (14)

Country Link
EP (1) EP1220606A4 (en)
JP (1) JP2003511048A (en)
KR (1) KR100772465B1 (en)
CN (1) CN1322003C (en)
AU (1) AU781944B2 (en)
BR (1) BR0014860A (en)
CA (1) CA2382741A1 (en)
HU (1) HUP0203537A2 (en)
IL (1) IL149003A0 (en)
MX (1) MXPA02003702A (en)
NO (1) NO20021686L (en)
NZ (1) NZ518263A (en)
RU (1) RU2002112460A (en)
WO (1) WO2001026455A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030049694A1 (en) * 2001-09-10 2003-03-13 Chung-Hsiun Wu Production of fusion proteins and use for identifying binding molecules
US6800462B2 (en) * 2001-09-10 2004-10-05 Abgenomics Corporation Production of recombinant proteins in vivo and use for generating antibodies
CN1283785C (en) * 2002-05-20 2006-11-08 上海杰隆生物工程股份有限公司 Method of producing human forcing erythrogenin using transgene animal mammary gland
WO2007052096A2 (en) * 2005-06-29 2007-05-10 Cameron Malcolm Lang Clokie Production of bone morphogenic proteins (bmps) in transgenic mammals
RU2010100911A (en) * 2007-06-13 2011-07-20 Стэрнбэлт Байэутекнолэджай Нос Эмерикэ, Инк. (US) PLASMIDA CONTAINING A NUCLEOTIDE SEQUENCE ENCODING A MODIFIED INSULIN PREVENTOR, AND THE METHOD OF ITS TRANSFECTION IN MAMMAL-LIVING CELLS IS MULTIER
WO2010036976A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
WO2010036978A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
US9150881B2 (en) 2009-04-09 2015-10-06 Proteovec Holding, L.L.C. Production of proteins using transposon-based vectors
CA2858825A1 (en) * 2011-12-19 2013-06-27 Lfb Usa, Inc. Recombinant human alpha-1-antitrypsin for the treatment of inflammatory disorders
CN105263319A (en) 2013-02-13 2016-01-20 法国化学与生物科技实验室 Proteins with modified glycosylation and methods of production thereof
JP2016508515A (en) 2013-02-13 2016-03-22 ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーLaboratoire Francais du Fractionnement et des Biotechnologies Highly galactosylated anti-TNF-α antibody and use thereof
AU2014285971A1 (en) 2013-07-05 2016-02-04 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Affinity chromatography matrix
FR3025515B1 (en) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement PROCESS FOR PURIFYING MONOCLONAL ANTIBODY
FR3034420A1 (en) 2015-03-31 2016-10-07 Lab Francais Du Fractionnement ANTI-CD303 MONOCLONAL ANTIBODIES
JP6712125B2 (en) * 2015-09-04 2020-06-17 株式会社フジクラ Connection structure of oxide superconducting wire and method for manufacturing the same
FR3060394B1 (en) 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies COMBINATION OF ANTI-CD303 AND ANTI-AMHRII ANTIBODIES
FR3060395B1 (en) 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies COMBINATION OF ANTI-CD303 AND ANTI-HER2 ANTIBODIES
FR3076294B1 (en) 2017-12-29 2022-01-28 Lab Francais Du Fractionnement METHOD FOR PURIFYING ANTIBODIES FROM RAW MILK
CA3223956A1 (en) 2021-12-20 2023-06-29 Vetoquinol Sa Anti-canine interleukine-31-receptor a (il-31ra) antibodies and the uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK580789D0 (en) * 1989-11-20 1989-11-20 Novo Nordisk As PROCEDURE FOR PURIFICATION OF POLYPEPTIDES
US5639940A (en) * 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
CN1114357A (en) * 1994-07-01 1996-01-03 唐勇炜 Process for producing recombinative polypeptide using transgene animal

Also Published As

Publication number Publication date
AU8025400A (en) 2001-04-23
EP1220606A1 (en) 2002-07-10
CN1387399A (en) 2002-12-25
KR100772465B1 (en) 2007-11-02
AU781944B2 (en) 2005-06-23
MXPA02003702A (en) 2002-09-18
HUP0203537A2 (en) 2003-02-28
CN1322003C (en) 2007-06-20
WO2001026455A1 (en) 2001-04-19
NZ518263A (en) 2004-03-26
IL149003A0 (en) 2002-11-10
CA2382741A1 (en) 2001-04-19
KR20030022759A (en) 2003-03-17
JP2003511048A (en) 2003-03-25
BR0014860A (en) 2003-07-08
EP1220606A4 (en) 2004-04-14
RU2002112460A (en) 2004-02-27
NO20021686L (en) 2002-06-12

Similar Documents

Publication Publication Date Title
NO20021686D0 (en) Methods for Preparation of Target Molecules in a Transgenic Animal and Purification of the Target Molecule
DE602004025101D1 (en) HUMAN ANTI-HUMANE CD3 BONDING MOLECULES
ATE412432T1 (en) INTERNALIZING ERBB2 ANTIBODIES
BRPI0415230A (en) bispecific antibody replacement for functional proteins
RS51847B (en) Binding molecules capable of neutralizing rabies virus and uses thereof
ATE248605T1 (en) CROSS-REACTIVE MONOCLONAL ANTIBODIES SPECIFIC FOR E-SELECTIN AND P-SELECTIN
DK2231860T3 (en) Polypeptide derived protein A and capable of binding PDGF
DK0906122T3 (en) Activated linkers and processes to manufacture and purify them
DK1553975T3 (en) Optimized Fc variants and methods for their generation.
NO20083268L (en) Antibodies designated for HER-3 and uses thereof
DE69932944D1 (en) COLONNE AND CHROMATOGRAPHIC METHOD THUS CARRIED OUT
FR2726286B1 (en) SOLID PHASE NUCLEIC ACID AMPLIFICATION PROCESS AND REAGENT KIT USEFUL FOR CARRYING OUT SAID PROCESS
ATE425989T1 (en) PROTEIN PURIFICATION PROCESS
NO20080362L (en) CD19 antibodies and their uses
WO2003061570A3 (en) Engineered binding proteins
NO932672L (en) MONOCLOAN ANTIBODIES AGAINST ELAM-1 AND APPLICATIONS THEREOF
DK1328297T3 (en) The function of a haptoglobin-hemoglobin receptor and its applications
DE602005027399D1 (en) FOR HUMAN MATRIPTASE SPECIFIC TIE PROTEINS
AU1922902A (en) Novel means for the diagnosis and therapy of CTCL
DK1536778T3 (en) Proteins that bind to cross-beta structural amyloid and methods for modulating cross-beta structure, its formation and its associated toxicity
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
DK1512015T3 (en) Methods for improving the binding properties of a molecule
DK1051491T3 (en) Equin Fc Epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and their use
MXPA05011577A (en) Cyclodextrin affinity purification.
ATE359263T1 (en) SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application